Veterinary CRO & CDMO Market Size, Share, By Animal Type (Companion Animals and Livestock Animals), By Service (Discovery, Development, Manufacturing, Packaging and Labeling, and Market Approval and Post-Marketing), By Application (Medicines and Medical Devices) and By Region - Trends, Analysis and Forecast till 2034

Veterinary CRO & CDMO market size was valued at USD 6.69 Billion in 2024 and is expected to reach at USD 15.27 Billion by 2034, growing at a CAGR of 9.5%

Veterinary CROs and CDMOs are highly specialized service providers dedicated to developing animal health. These organizations cover all-inclusive services from preclinical activities to product commercialization for developing and commercializing veterinary pharmaceuticals, biologics, and medical devices. The research and development phase of product development in a company is primarily the most targeted by CROs. This comprises preclinical studies, conduct of clinical trials, regulatory affairs, and data management. Outsourcing these tasks to CROs helps pharmaceutical and biotech companies quicken drug development, reduce expenses, and increase efficiency. CROs and CDMOs operating in the veterinary sector, therefore, play a very instrumental role in providing services that strongly support innovation and ultimately bring new treatments to the marketplace.

 They help drive forward improvements in animal health and welfare by adding their expertise, infrastructure, and regulatory know-how. At its very core, CDMOs concentrate on drug development and manufacturing: services involve formulation development, analytic testing, optimization of processes, and manufacturing in large quantities. Using a CDMO provides access to state-of-the-art facilities, specialized equipment, and experienced people but stays focused on core competencies and ensures the quality and compliance of products. The industry has experienced significant expansion due to the rise in animal ailments like cancer and zoonotic infections. As a result, there is now a greater demand for cutting-edge veterinary biologics and medications.

Additionally, the growing number of livestock and the heightened emphasis on pet healthcare fuel the need for novel treatments. Research and development efforts have increased in response to the need for sophisticated therapies to speed up the discovery of new drugs. Because of this, businesses in the pharmaceutical and biotechnology industries depend more on specialized CROs and CDMOs to take advantage of their knowledge, quicken the pace of product development, guarantee regulatory compliance, and effectively launch superior animal health solutions. Therefore, the industry will increase if CRO and CDMO services are widely adopted.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Key Drivers of Target Market:

Increasing Prevalence of Animal Diseases

• The increased incidence of, among others, zoonotic diseases is presenting major concerns for both health and animal welfare. This, in turn, is because it imparts a pressing need to develop the most appropriate ways of prevention, diagnosis, and treatment, which has generally increased demand for veterinary pharmaceuticals. The CROs and CDMOs are also vital for expediting the development, safety, and efficacy of such important medicated drugs and ensuring improved outcomes in animal health.

Rising Pet Population and the Humanization of Pets

• As the number of companion animals increases worldwide and with the increasing trend of humanization of pets, demand for advanced veterinary care also rises. Added to this is that pet owners seek quality healthcare options for their beloved companions, thereby stimulating the need to develop innovative veterinary products and services. Such increased demand thus translates to a higher volume of drug development projects for CROs and CDMOs, thus stimulating market growth.

Increasing Investment in Animal Healthcare

• Growing animal health and welfare awareness is pumping huge investments into veterinary research and development. Pharmaceutical companies, biotechnology firms, and government agencies invest heavily in developing novel and advanced treatments against animal diseases. The CROs and CDMOs benefit from the increased investments through these critical services that help support research efforts, drug development pace, product quality, and compliance.

 Restrains:

High Development Costs, Small Market Size

• Veterinary drug development and manufacturing are expensive processes; they could be even better if the market for veterinary drugs was as large as it is for human pharmaceuticals. This impacts the variety of projects CROs and CDMOs can execute and, consequently, their potential revenue. That said, growth in this market is now driven by increased valuing of animal health, and with time and further investment, economies of scale may help temper at least some of these cost challenges a little.

Regulatory Hurdles

• Ensuring compliance with a complex, changing veterinary drug regulatory landscape is a significant challenge for CROs and CDMOs regarding compliance and time-to-market. Keeping pace with changing regulations and following guidelines requires substantial resources. However, those CROs and CDMOs with robust regulatory expertise can set themselves apart and create a competitive edge.

 Opportunities:

Emerging Market Entry

• The growing pet population and increasing awareness of animal health in developing economies spell huge growth potential for veterinary CROs and CDMOs. A strong presence in such markets, coupled with the requirement of tailoring services to local needs and regulations, will enable the realization of a large customer base. It is also the case that rising exposure to zoonotic diseases in emerging markets increases the requirement for efficient animal healthcare, which will raise demand for professional veterinary products and services.

Therapeutic Specialization

• In this regard, paying specific attention to oncology, infectious diseases, companion animal care, or other focused therapeutic areas can lend a differentiated market-leading position to CROs and CDMOs by better addressing the increasing demand for specialized treatments. CROs achieve this by putting firms in a position to gain in-depth expertise and strong relations with clients interested in certain diseases. Besides, in contributing to developing trends in veterinary medicine, such as personalized medicine and gene therapy, the CROs and CDMOs set themselves at the forefront in their respective activities.

The market is segmented based on Animal Type, Service, Application, and Region.

By Animal Type:

• Companion Animals: Form a significant market share owing to growing human-animal bonding and the increasing number of pets in the population. New treatments and diagnostics for companion animals, which require sophisticated veterinary care, open up more potential for the CRO and CDMO market.
• Livestock Animals: The livestock industry is making a huge contribution to the veterinary CRO and CDMO market because of fast-moving initiatives for animal health and productivity. The need to prevent diseases, welfare, and food safety maintains a high demand for services related to CRO and CDMO in this area.

By Service:

• Discovery: The discovery stage involves the identification and validation of drug targets, preclinical research with in vitro and in vivo studies, lead optimization, and formulation of drug candidates. Thus, CROs become very important in this early stage by providing intellectual input for target identification, hit-to-lead optimization, and preclinical pharmacology studies. Besides, safety assessments, like toxicity studies and pharmacokinetic evaluations, will be performed to establish the safety and efficacy of a possible drug candidate.
• Development: In the development stage, formulation development is done, followed by process optimization, development and validation of analytical methods, and clinical trials. Therefore, the close integration between CROs and CDMOs ensures that drug candidates translated from a laboratory are successfully transitioned to the clinic. The CROs bring knowledge and experience in the design of clinical trials, protocol development, patient recruitment, data management, and regulatory affairs. The CDMOs, on their part, do formulation development, manufacturing process optimization, and the production of clinical trial materials.
• Manufacturing: CDMOs specialize in large-scale production of quality, consistency, and compliance according to regulatory standards for the product. Services include manufacturing active pharmaceutical ingredients, formulation development, filling, packaging, and labeling. This also includes essential functions related to supply chain management and distribution.
• Packaging and Labeling: This includes designing package material and its manufacturing process, labeling the product, and developing artwork. It also includes packaging tests and validation to ensure the integrity of the product and regulatory compliance.
• Market Approval and Post-Marketing: The support that CROs and CDMOs offer extends to all regulatory filings, gaining market approvals, and the management of post-marketing surveillance activities. Not only do they help in the preparation of regulatory documentation but also in conducting post-approval studies and ensuring there is compliance with the requirements of regulators from time to time. CROs are involved in pharmacovigilance activities, monitoring product safety, and managing adverse event reporting.

By Application:

• Medicines: The largest proportion of the market comes from developing and manufacturing veterinary pharmaceuticals. This segment is driven by the rising prevalence of diseases across animal populations and the need for effective treatments against them.
• Medical Devices: The use of medical devices in veterinary care is still in its relative infancy, but opportunities remain for CROs and CDMOs in development and manufacturing services.

Regional Insights

• North America: Rigid regulatory frameworks, advanced infrastructure, and established players make this region lead in the Veterinary CRO and CDMO market. The United States is home to a highly developed pharmaceutical industry, and massive investment is being made in animal healthcare; this is why the country dominates CRO and CDMO activities in North America. There are many large CRO and CDMOs in this region, which offer services from early drug discovery up to commercial manufacturing. Additionally, leading pharmaceutical companies and biotechnology firms in North America create robust demand for services in CRO and CDMO.
• Europe: The European market is characterized by an intensive focus on animal welfare and a growing demand for innovative veterinary products. This region has a well-laid and binding regulatory framework for veterinary medicines and a mature CRO and CDMO landscape. In specific terms, Germany, the United Kingdom, and France exhibit robust linkages to the veterinary pharmaceutical industry, thereby creating demand for CRO and CDMO services to be offered in these countries. The market growth is driven by rising concern about research and development within the European Union due to the increased population of pets.
• Asia Pacific is growing fast in terms of pet adoption, disposable income, and investments in the animal healthcare sector. Countries such as China, India, and Japan will be high-growth markets for the veterinary industry, thus paving the way for the CRO and CDMO industries. High population counts and increasing pet penetrations characterize this region, with growing demand for veterinary products and services. In addition, the growing concern about animal welfare and food safety is offering a favorable environment for the CRO and CDMO market.
• Latin America: The Latin American market is one of the growing markets for veterinary CROs and CDMOs. The growth of the middle class has brought growing pet ownership and greater concern for animal health in the region, fueling the demand for veterinary services. Although at an earlier stage of the market than North America and Europe, the market in Latin America offers immense growth potential.
• Middle East and Africa: The situation in this region is mixed concerning the veterinary CRO and CDMO market. Countries in the Middle East, such as Saudi Arabia and the United Arab Emirates, have been witnessing an increased interest in animal healthcare and are investing hugely in developing their veterinary industries. However, the market needs to be developed more. This contrasts with Africa, where infrastructural and economic challenges could be a barrier to growing the market for veterinary CROs and CDMOs. However, this also provides an opportunity for the existence of those CROs and CDMOs focused solely on serving the needs of the respective markets.

Veterinary CRO & CDMO Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study segmented the target market report based on Animal type, Service, Application and Region.

Segmentation:

By Animal Type:

• Companion Animals
• Livestock Animals

By Service:

• Discovery
• Development
•  Manufacturing
•  Packaging and Labeling
• Market Approval and Post-Marketing

By Application:

• Medicines
• Medical Devices

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Veterinary CRO & CDMO Market include Labcorp Drug Development, Charles River Laboratories., Clinvet., Klifovet GmbH, Oncovet Clinical Research (OCR), Knoell Triveritasm, Vetspin, Inotiv.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

• In June 2023, Transpharmation Canada Ltd., the largest niche neuroscience-specialized small and large animal contract research organization (CRO), and a leading neurocognitive focused biotechnology company, and Veterinary Health Research Centers LLC (VHRC), a niche CRO specializing in providing disease-relevant canines and felines with spontaneous naturally occurring conditions for researchers, have announced their strategic marketing partnership at the Animal Health, Nutrition & Technology Innovation USA Conference. Designed to accelerate drug discovery programs by providing high-quality, translational drug discovery services, this collaboration will enable a seamless transition of preclinical work conducted by Transpharmation into Proof of Concept or pre-IND/INAD clinical trials using animals with real-world conditions traditionally unavailable in research colonies.
• In May 2023, Argenta, the only combined global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) dedicated to animal health and nutrition, tannounced that it has agreed to acquire the CRO services of Midwest Veterinary Services, Inc., a pioneer in the veterinary clinical space.

• Labcorp Drug Development

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies

• Charles River Laboratories.
•  Clinvet.
•  Klifovet GmbH
•  Oncovet Clinical Research (OCR)
•  Knoell Triveritasm
•  Vetspin
•  Inotiv

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

Market Preview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Animal Type
  • Market Snippet, By Service
  • Market Snippet, By Application
  • Market Snippet, By Region
• Opportunity Map Analysis

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Market Trends
• Product Launch
• Merger and Acquisitions
• Impact Analysis
• PEST Analysis
• Porter’s Analysis

Market Segmentation, Animal Type, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Companion Animals
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Livestock Animals
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Segment Trends

Market Segmentation, Service, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Discovery
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Development
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Manufacturing
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Packaging and Labeling
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Market Approval and Post-Marketing
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Application, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Medicines
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Medical Devices
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Service, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • U.S
    • Canada
• Asia Pacific
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Service, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Europe
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Service, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
• Latin America
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Service, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Service, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East and Africa

Competitive Landscape

• Heat Map Analysis
• Company Profiles

• Labcorp Drug Development
• Charles River Laboratories.
•  Clinvet.
•  Klifovet GmbH
•  Oncovet Clinical Research (OCR)
•  Knoell Triveritasm
•  Vetspin
•  Inotiv

The Last Word

• Future Impact
• About Us
• Contact